Arian Lundberg (18 publications)

Primary: Shown in the list of current labels.

Year 2025

Early gonadotoxic effects of cyclophosphamide on the prepubertal testis and the feasibility of reducing toxicity through combined antioxidant therapy.

Eskafinoghani A, Palomares AR, Hao X, ..., Lundberg A, Rodriguez-Walberg KA

Reprod. Toxicol. 140 (-) 109156 [2025-12-29; online 2025-12-29]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Chesner LN, Polesso F, Graff JN, ..., Feng FY, Moran AE

Cancer Discov 15 (3) 481-494 [2025-03-03; online 2024-12-09] Open Access

Arian Lundberg DDLS Fellow

Year 2024

PubMed DOI Crossref

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.

Seed G, Beije N, Yuan W, ..., Carreira S, de Bono J

Cancer Cell 42 (12) 2113-2123.e4 [2024-12-09; online 2024-11-21]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.

Calì B, Troiani M, Bressan S, ..., de Bono J, Alimonti A

Cancer Cell 42 (10) 1676-1692.e11 [2024-10-14; online 2024-09-19]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.

Westaby D, Jiménez-Vacas JM, Figueiredo I, ..., de Bono J, Sharp A

J. Clin. Invest. 134 (18) - [2024-09-17; online 2024-09-17]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.

Shrestha R, Chesner LN, Zhang M, ..., Quigley DA, Feng FY

Cancer Res. 84 (18) 3086-3100 [2024-09-16; online 2024-07-11]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.

Zhu X, Farsh T, Vis D, ..., van der Heijden MS, Feng FY

J. Clin. Invest. 134 (19) - [2024-08-13; online 2024-08-13]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer.

Zhao SG, Bootsma M, Zhou S, ..., Lupien M, Feng FY

Nat. Genet. 56 (8) 1689-1700 [2024-08-00; online 2024-07-17]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.

Zhang M, Sjöström M, Cui X, ..., Feng FY, Quigley DA

Nat. Cell Biol. 26 (7) 1176-1186 [2024-07-00; online 2024-06-13]

Arian Lundberg DDLS Fellow

Year 2023

PubMed DOI Crossref

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.

Lundberg A, Zhang M, Aggarwal R, ..., Small EJ, Quigley DA

Cancer Res. 83 (16) 2763-2774 [2023-08-15; online 2023-06-08]

Arian Lundberg DDLS Fellow

Year 2022

PubMed DOI Crossref

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer.

Feng E, Rydzewski NR, Zhang M, ..., Sjöström M, Zhao SG

Clin. Cancer Res. 28 (24) 5396-5404 [2022-12-15; online 2022-10-20]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.

Sjöström M, Zhao SG, Levy S, ..., Quigley DA, Feng FY

Cancer Res. 82 (21) 3888-3902 [2022-11-02; online 2022-10-18]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Reclassifying tumour cell cycle activity in terms of its tissue of origin.

Lundberg A, Yi JJJ, Lindström LS, Tobin NP

NPJ Precis Oncol 6 (1) 59 [2022-08-20; online 2022-08-20]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

Lundberg A, Li B, Li R

Br. J. Cancer 126 (6) 899-906 [2022-04-00; online 2021-12-17]

Arian Lundberg DDLS Fellow

Year 2020

PubMed DOI Crossref

A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels.

Lundberg A, Lindström LS, Parker JS, ..., Bergh J, Tobin NP

Oncogene 39 (32) 5430-5440 [2020-08-00; online 2020-06-24]

Arian Lundberg DDLS Fellow

Year 2019

PubMed DOI Crossref

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.

Lundberg A, Lindström LS, Li J, ..., Bergh J, Tobin NP

Breast Cancer Res. 21 (1) 34 [2019-02-28; online 2019-02-28]

Arian Lundberg DDLS Fellow

Year 2017

PubMed DOI Crossref

Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.

Lundberg A, Lindström LS, Harrell JC, ..., Bergh J, Tobin NP

Clin. Cancer Res. 23 (24) 7512-7520 [2017-12-15; online 2017-09-29]

Arian Lundberg DDLS Fellow

PubMed DOI Crossref

PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients.

Tobin NP, Lundberg A, Lindström LS, ..., Hatschek T, TEX Trialists Group

Clin. Cancer Res. 23 (23) 7225-7231 [2017-12-01; online 2017-09-29]

Arian Lundberg DDLS Fellow